Coronavirus (COVID-19) vaccine - Comirnaty® 10 micrograms/dose (mRNA, Pfizer/BioNTech): national protocol v1.0

Protocol for the supply and administration of Comirnaty® 10 micrograms/dose (COVID-19 mRNAVaccine, Pfizer/BioNTech) national protocol v1.0.

5. Clinical condition or situation to which this Protocol applies

Comirnaty® 10 micrograms/dose (COVID-19 mRNA Vaccine, Pfizer/BioNTech) is indicated for active immunisation against COVID-19 disease caused by SARS-CoV-2 virus in accordance with Scottish Government COVID-19 immunisation programme and recommendations given in Chapter 14a of the Immunisation Against Infectious Disease: the ‘Green Book’ COVID-19: the green book, chapter 14a - GOV.UK ( and Scottish Government CMO letters relating to COVID-19 vaccination.



Back to top